Cita APA (7a ed.)

Wang, J., Ling, S., Ni, J., & Wan, Y. (2022). Novel γδ T cell-based prognostic signature to estimate risk and aid therapy in hepatocellular carcinoma. BMC.

Cita Chicago Style (17a ed.)

Wang, Jingrui, Sunbin Ling, Jie Ni, y Yafeng Wan. Novel γδ T Cell-based Prognostic Signature to Estimate Risk and Aid Therapy in Hepatocellular Carcinoma. BMC, 2022.

Cita MLA (9a ed.)

Wang, Jingrui, et al. Novel γδ T Cell-based Prognostic Signature to Estimate Risk and Aid Therapy in Hepatocellular Carcinoma. BMC, 2022.